Insights

Security is a problem, right? Well there's a radically different way to view it – as a positive force capable of putting clear water between you and your competitors. 

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Metered-dose inhalers account for 3.5% of the UK National Health Service’s carbon footprint and are tagged as a carbon hotspot. But there is no reason that sustainability has to come at the cost of clinical benefit. 

The events of 2020 have accelerated the adoption of telemedicine, but to ensure success, devices need to be easy to use and data security is paramount. 

Gavin Troughton examines the strategies that creators of telemedicine ecosystems will need to consider to encourage sustained telemedicine usage by healthcare professionals post-COVID-19.

Ryan Chaves explores some of the approaches currently being used – or considered – to address concerns over the cybersecurity of implanted medical devices.

“You mean you just want me to throw all that packaging away? There’s enough waste here to fill three trash cans!” The fact that we repeatedly get feedback like this during patient interviews these days highlights just how important the environmental impact of a product has become.

With fewer than 100 days of the Brexit transition period remaining, it’s clear that medical device manufacturers will need to respond efficiently to the new regulatory developments. Sara Dodd looks at the unfolding new regulatory landscape.

Despite intense media focus and impassioned societal debate, meaningful progress on climate change is a glacially slow business - this is particularly true in the medical device sector. Dan Cowen explores how radical technological innovation is the way forward.

With many industry leaders presenting, the event promised to peel back the layers of these thriving ecosystems and offer unique insights. And it didn’t disappoint...

The race is on to develop the technology that will enable next-generation smart implants and contact lenses to diagnose, monitor and treat a wide range of chronic and degenerative diseases.

As the debate moves on – and as we continue to learn from real-world deployments rather than abstract research – it seems like a good time to revisit our core principles for responsible AI. What should we be considering when we develop and deploy AI?